Durability of non-nucleotide reverse transcriptase inhibitor-based first-line ART regimens after 7 years of treatment in rural Uganda-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Durability of non-nucleotide reverse transcriptase inhibitor-based first-line ART regimens after 7 years of treatment in rural Uganda

Published:2021-05-14 Issue:19 Volume:100 Page:e25763
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Nanfuka Mastula,Forrest Jamie I.,Zhang Wendy,Okoboi Stephen,Birungi Josephine,Kaleebu Pontiano,Zhu Julia,Tibenganas Samuel,Moore David M.

Funder

Canadian Institutes of Health Research

Michael Smith Foundation for Health Research

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference11 articles.

1. Prevention of HIV-1 infection with early antiretroviral therapy;Cohen;N Engl J Med,2011

2. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda;Mills;Ann Intern Med,2011

3. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings;Gilks;Lancet,2006

4. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial;Mermin;BMJ (clinical research ed),2011

5. Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand;Jourdain;PLoS Med,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV1 drug resistance among patients experiencing first-line treatment failure in Ethiopia: protocol for a systematic review and meta-analysis;Systematic Reviews;2024-07-15

2. Ongoing Healthcare Disparities in neuroHIV: Addressing Gaps in the Care Continuum;Current HIV/AIDS Reports;2023-11-24

3. Limited Impact of First-Line Drug Resistance Mutations on Virologic Response Among Patients Receiving Second-Line Antiretroviral Therapy in Rural Uganda;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-01-01

4. Efavirenz: History, Development and Future;Biomolecules;2022-12-31

5. Real-time assessment of adherence to antiretroviral drugs: a moving target;AIDS;2022-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3